Fibrosis Frontiers: From Basic Mechanisms to Precision Therapies (L1)
March 1-4, 2027  | Keystone Resort, Keystone, CO, United States
Rafael Kramann, Rebekka Schneider and Neil C. Henderson
Scholarship Deadline: Nov. 5, 2026 | Abstract Deadline: Feb. 10, 2027 | Early Registration Deadline: Dec. 31, 2026
* Session Chair † Invited but not yet accepted | Program current as of November 16, 2026 12 AM | For the most up-to-date details, visit https://www.keystonesymposia.org
Monday, March 1, 2027
4:00–8:00 PM Registration Longs Peak Foyer
6:00–8:00 PM Welcome Mixer Longs Peak Foyer
Tuesday, March 2, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–8:10 AM Welcome Remarks Longs Peak
8:10–9:00 AM Keynote Address Longs Peak
  Carine Boustany, Boehringer Ingelheim
Drug Discovery in Fibrosis
 
9:00–11:15 AM Developing Novel Therapeutics in Fibrotic Disease Longs Peak
  Thomas A Wynn, Pfizer
Anti-Inflammatory Therapeutics in Organ Fibrosis
 
  Paul J Yaworsky, Mediar Therapeutics
Targeting EphrinB2 and SMOC2 in Fibrotic Disease
 
  Catherine Hines, GlaxoSmithKline
Biomarkers and Imaging as Readouts in Clinical Testing
 
  Short Talk(s) Chosen from Abstracts
 
9:30–9:50 AM Coffee Break Longs Peak Foyer
11:15–11:20 AM Jessica Langer, Helmsley Trust Introduction Longs Peak
11:25–12:25 PM Meet the Editors Longs Peak
12:25–1:00 PM Poster Setup Quandary Peak
12:25–2:30 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Quandary Peak
2:30–4:30 PM Symposia Spotlight 1 Longs Peak
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM From Identification of Novel Therapies to Early Clinical Testing in Fibrosis Longs Peak
  Rachel Lennon, University of Manchester
Novel Therapies for Scarring of the Glomerulus
 
  Rebekka Schneider, Erasmus MC
From Single Cell Genomics to Novel Targets in Fibrotic Disease and Clinical Testing
 
  Frank A Anania, US Food and Drug Administration
Regulatory Steps Towards Approval of Novel Antifibrotic Therapies
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Quandary Peak
7:30–10:00 PM Poster Session 1 Quandary Peak
Wednesday, March 3, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–11:00 AM Mapping Fibrotic Disease using Single Cell and Spatial Genomics Longs Peak
  Rafael Kramann, RWTH Aachen University
Mapping Kidney and Cardiac Fibrosis to Identify Novel Therapeutic Targets
 
  Neil C. Henderson, Institute of Regeneration and Repair, University of Edinburgh
Spatial Mapping of Human Liver Fibrosis
 
  Jörg H Distler, University Hospital Düsseldorf
Mapping Pulmonary and Skin Fibrosis
 
  Benjamin D. Humphreys, Washington University
Single Cell and Spatial Genomics to Map Kidney Fibrosis
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:10–12:10 PM Panel Discussion 1: How to Launch a Startup Longs Peak
  Rafael Kramann, RWTH Aachen University
 
  Rebekka Schneider, Erasmus MC
 
  Neil C. Henderson, Institute of Regeneration and Repair, University of Edinburgh
 
  Paul J Yaworsky, Mediar Therapeutics
 
12:10–1:00 PM Poster Setup Quandary Peak
12:10–3:00 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Quandary Peak
3:00–4:30 PM Career Roundtable Longs Peak
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Fibrosis in Cancer and Aging Longs Peak
  Natalie J. Torok, Stanford University
The Role of Matrix in Liver Cancer Progression and Aging
 
  Simón Méndez-Ferrer, University of Cambridge
Mechanisms of Fibrosis Hematopoietic Malignancies
 
  Melanie Koenigshoff, University of Pittsburgh
Role of Senescence and Aging in Pulmonary Fibrosis
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM Social Hour with Dinner Quandary Peak
7:30–10:00 PM Poster Session 2 Quandary Peak
Thursday, March 4, 2027
7:00–8:00 AM Breakfast Quandary Peak
8:00–11:00 AM Organ Specific and Conserved Mechanisms of Organ Fibrosis Longs Peak
  Valerie Horsley, Yale University
Mechanisms of Skin Fibrosis
 
  Meritxell Huch, Max Planck Institute of Molecular Cell Biology and Genetics
Modeling Fibrosis ex vivo
 
  Katalin Susztak, University of Pennsylvania
Mechanisms of Kidney Fibrosis
 
  Kory J. Lavine, Washington University School of Medicine
Mechanisms of Cardiac Fibrosis
 
  Short Talk(s) Chosen from Abstracts
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:10–12:10 PM Panel Discussion 2: Why Are We not Seeing Progress / Therapeutic Success in Some Areas? What Are We Missing and How can We Address these Challenges/ Lessons from Clinical Trials? Longs Peak
12:10–2:30 PM On Own for Lunch
2:30–4:30 PM Symposia Spotlight 2: AI & Big Data in Drug Development Longs Peak
  Short Talks Chosen from Abstracts
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–6:45 PM Need for Multimodal Therapies, New Modalities and Lessons Learned from Clinical Trials Longs Peak
  Grant Budas, Gilead
Multimodal Therapies for Fibrotic Disease
 
  Vincent F Fiore, Boehringer Ingelheim
Mechanisms of Fibrosis in IBD, Boehringer Ingelheim
 
  Scott L Friedman, Icahn School of Medicine at Mount Sinai
Lessons Learned from Clinical Trials and Regulatory Aspects in Fibrotic Disease
 
  Short Talk(s) Chosen from Abstracts
 
6:45–7:00 PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Longs Peak
7:00–8:00 PM Social Hour with Dinner Quandary Peak
8:00–9:00 PM Entertainment Quandary Peak
8:00–9:00 PM Cash Bar Quandary Peak
Friday, March 5, 2027
12:00–11:59 PM Departure